These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38788824)

  • 101. The Gastrointestinal Risks of Combining NSAIDs and Endurance Exercise.
    Langland JT
    Am J Med; 2024 Sep; 137(9):e161. PubMed ID: 38788824
    [No Abstract]   [Full Text] [Related]  

  • 102. NSAIDs: a clinical approach to the problems of gastrointestinal side-effects.
    Butt JH; Barthel JS; Hosokawa MC; Moore RA
    Aliment Pharmacol Ther; 1988; 2 Suppl 1():121-9. PubMed ID: 2979280
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Gastrointestinal protection by NO from NSAIDs induced injury.
    Rishi RK; Kishore K; Seth SD
    Indian J Physiol Pharmacol; 1996 Oct; 40(4):377-9. PubMed ID: 9055111
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs).
    Simadibrata M
    Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719
    [No Abstract]   [Full Text] [Related]  

  • 105. NSAIDs and the gastrointestinal tract.
    Lanza FL
    Abdom Imaging; 1997; 22(1):1-4. PubMed ID: 9000344
    [No Abstract]   [Full Text] [Related]  

  • 106. NSAIDs and the gastrointestinal tract--case closed?
    Aabakken L
    Scand J Gastroenterol; 1991 Aug; 26(8):801-5. PubMed ID: 1771383
    [No Abstract]   [Full Text] [Related]  

  • 107. The risks and costs of upper gastrointestinal disease attributable to NSAIDs.
    Smalley WE; Griffin MR
    Gastroenterol Clin North Am; 1996 Jun; 25(2):373-96. PubMed ID: 9229579
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Mitigating GI risks associated with the use of NSAIDs.
    Momeni M; Katz JD
    Pain Med; 2013 Dec; 14 Suppl 1():S18-22. PubMed ID: 24373106
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Developing nonsteroidal anti-inflammatory drugs (NSAIDs) with decreased gastrointestinal (GI) toxicity.
    Goldlust B; Doucette M; Verduyn C
    Agents Actions Suppl; 1991; 32():27-31. PubMed ID: 2069094
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Cardiovascular and gastrointestinal safety of NSAIDs].
    van den Bemt P; Tjwa ET; van Oijen MG
    Ned Tijdschr Geneeskd; 2014; 158():A7311. PubMed ID: 24713339
    [TBL] [Abstract][Full Text] [Related]  

  • 111.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 112.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.